Ron Graybill
Senior Vice President, Value and Access
Ron is Senior Vice President of Value and Access. In this role, he leads the Strategic Pricing, Account Management, Trade & Distribution, Reimbursement, and Patient Services functions. He is an accomplished managed-markets professional with expertise in consultative sales, marketing, pricing strategies, product revitalization, and life-cycle management.
Prior to joining Ipsen in 2014, Ron was Vice President, Managed Markets, at Mylan Specialty, where he provided strategic direction to senior executives to ensure long-term growth and profitability for Mylan’s branded, generic, and biosimilar businesses. He has also held positions at Bayer HealthCare Pharmaceuticals Inc., Novartis, and Hoechst Roussel Pharmaceuticals, Inc,.
Ron earned his MBA in Finance from Fairleigh Dickinson and an undergraduate degree in Economics from Rutgers University–New Brunswick.
Our mission?
To improve patients’ lives
Acting on this mission has propelled us to become a global biopharmaceutical leader with a focus on innovation and specialty care. We help patients through our expertise in oncology, neuroscience, and rare diseases.
Find out more about us or see other members of our leadership team.
About
Products and partnerships
Partnering
Access our development and commercialization teams. We take bold steps to translate your science and innovations into solutions that make a difference for patients in need.
See more on partneringProducts and partnerships
What’s happening now?